| 1 | Diabetes is a risk factor for the progression and prognosis of COVID‐19 | Diabetes/Metabolism Research and Reviews | 2020 | 1,249 |
| 2 | Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes | Diabetes/Metabolism Research and Reviews | 1999 | 1,213 |
| 3 | Quality of life and diabetes | Diabetes/Metabolism Research and Reviews | 1999 | 918 |
| 4 | Phlorizin: a review | Diabetes/Metabolism Research and Reviews | 2005 | 868 |
| 5 | The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society | Diabetes/Metabolism Research and Reviews | 2001 | 789 |
| 6 | Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management | Diabetes/Metabolism Research and Reviews | 2011 | 785 |
| 7 | Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 647 |
| 8 | Standards of medical care for type 2 diabetes in China 2019 | Diabetes/Metabolism Research and Reviews | 2019 | 580 |
| 9 | Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 564 |
| 10 | IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes | Diabetes/Metabolism Research and Reviews | 2016 | 469 |
| 11 | Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy | Diabetes/Metabolism Research and Reviews | 2012 | 462 |
| 12 | Common infections in diabetes: pathogenesis, management and relationship to glycaemic control | Diabetes/Metabolism Research and Reviews | 2007 | 448 |
| 13 | Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19) | Diabetes/Metabolism Research and Reviews | 2021 | 430 |
| 14 | Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity | Diabetes/Metabolism Research and Reviews | 2011 | 428 |
| 15 | International consensus and practical guidelines on the management and the prevention of the diabetic foot | Diabetes/Metabolism Research and Reviews | 2000 | 422 |
| 16 | Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors | Diabetes/Metabolism Research and Reviews | 2022 | 417 |
| 17 | Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases | Diabetes/Metabolism Research and Reviews | 2006 | 408 |
| 18 | Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies | Diabetes/Metabolism Research and Reviews | 2004 | 404 |
| 19 | Practical guidelines on the management and prevention of the diabetic foot 2011 | Diabetes/Metabolism Research and Reviews | 2012 | 378 |
| 20 | Glucose-stimulated signaling pathways in biphasic insulin secretion | Diabetes/Metabolism Research and Reviews | 2002 | 356 |
| 21 | Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 354 |
| 22 | The mode of action of thiazolidinediones | Diabetes/Metabolism Research and Reviews | 2002 | 353 |
| 23 | Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management | Diabetes/Metabolism Research and Reviews | 2011 | 347 |
| 24 | Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice | Diabetes/Metabolism Research and Reviews | 2000 | 333 |
| 25 | What is the most effective way to reduce incidence of amputation in the diabetic foot? | Diabetes/Metabolism Research and Reviews | 2000 | 331 |
| 26 | Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection | Diabetes/Metabolism Research and Reviews | 2004 | 329 |
| 27 | Intermediate metabolism in normal pregnancy and in gestational diabetes | Diabetes/Metabolism Research and Reviews | 2003 | 325 |
| 28 | Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease | Diabetes/Metabolism Research and Reviews | 2006 | 323 |
| 29 | Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review | Diabetes/Metabolism Research and Reviews | 2011 | 309 |
| 30 | Vascular disease and diabetes: is hypoglycaemia an aggravating factor? | Diabetes/Metabolism Research and Reviews | 2008 | 302 |
| 31 | The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence‐based global consensus | Diabetes/Metabolism Research and Reviews | 2016 | 300 |
| 32 | Practical guidelines on the management and prevention of the diabetic foot | Diabetes/Metabolism Research and Reviews | 2008 | 299 |
| 33 | Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment | Diabetes/Metabolism Research and Reviews | 2014 | 297 |
| 34 | Patient perceptions of diabetes and diabetes therapy: assessing quality of life | Diabetes/Metabolism Research and Reviews | 2002 | 290 |
| 35 | Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction | Diabetes/Metabolism Research and Reviews | 2006 | 289 |
| 36 | Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 288 |
| 37 | Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review | Diabetes/Metabolism Research and Reviews | 2016 | 287 |
| 38 | Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein | Diabetes/Metabolism Research and Reviews | 2010 | 283 |
| 39 | The AGE‐receptor in the pathogenesis of diabetic complications | Diabetes/Metabolism Research and Reviews | 2001 | 276 |
| 40 | Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment | Diabetes/Metabolism Research and Reviews | 2008 | 272 |
| 41 | Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance | Diabetes/Metabolism Research and Reviews | 2004 | 271 |
| 42 | Standards of care for type 2 diabetes in China | Diabetes/Metabolism Research and Reviews | 2016 | 269 |
| 43 | Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives | Diabetes/Metabolism Research and Reviews | 2003 | 268 |
| 44 | Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis | Diabetes/Metabolism Research and Reviews | 2012 | 268 |
| 45 | Circulating levels of free insulin-like growth factors in obese subjects: the impact of Type 2 diabetes | Diabetes/Metabolism Research and Reviews | 1999 | 267 |
| 46 | Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents | Diabetes/Metabolism Research and Reviews | 2016 | 264 |
| 47 | Definitions and criteria for diabetic foot disease | Diabetes/Metabolism Research and Reviews | 2020 | 263 |
| 48 | Sensors for glucose monitoring: technical and clinical aspects | Diabetes/Metabolism Research and Reviews | 2001 | 261 |
| 49 | IWGDF guidance on the prevention of foot ulcers in at‐risk patients with diabetes | Diabetes/Metabolism Research and Reviews | 2016 | 261 |
| 50 | Glucagon-like peptide 1(GLP-1) in biology and pathology | Diabetes/Metabolism Research and Reviews | 2005 | 260 |